The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits
暂无分享,去创建一个
[1] Amit Kumar,et al. The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells , 2018, EBioMedicine.
[2] P. Tomasec,et al. The pentameric complex drives immunologically covert cell–cell transmission of wild-type human cytomegalovirus , 2017, Proceedings of the National Academy of Sciences.
[3] J. Díaz-Chávez,et al. Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer. , 2017, Oncology reports.
[4] R. Kalejta,et al. Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins , 2017, The Journal of Biological Chemistry.
[5] Haluk Resat,et al. Constitutive activation of STAT3 in breast cancer cells: A review , 2016, International journal of cancer.
[6] Zigang Dong,et al. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer , 2016, EBioMedicine.
[7] T. Rebbeck,et al. Distinct microbiological signatures associated with triple negative breast cancer , 2015, Scientific Reports.
[8] M. Weekes,et al. Human cytomegalovirus: taking the strain , 2015, Medical Microbiology and Immunology.
[9] Brent J. Ryckman,et al. A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism , 2015, Proceedings of the National Academy of Sciences.
[10] L. Castellano,et al. Mammosphere formation assay from human breast cancer tissues and cell lines. , 2015, Journal of visualized experiments : JoVE.
[11] R. Rappuoli,et al. Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes , 2015, Proceedings of the National Academy of Sciences.
[12] R. Büttner,et al. c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia , 2014, Oncotarget.
[13] J. Joyce,et al. Pericellular proteolysis in cancer , 2014, Genes & development.
[14] M. Ando,et al. Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] Amit Kumar,et al. The Oncogenic Potential of Human Cytomegalovirus and Breast Cancer , 2014, Front. Oncol..
[16] Yongchao Ge,et al. Human Cytomegalovirus Modulates Monocyte-Mediated Innate Immune Responses during Short-Term Experimental Latency In Vitro , 2014, Journal of Virology.
[17] S. Warming,et al. Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109 , 2014, Proceedings of the National Academy of Sciences.
[18] A. Krešo,et al. Evolution of the cancer stem cell model. , 2014, Cell stem cell.
[19] P. Maes,et al. Genomic and Functional Characteristics of Human Cytomegalovirus Revealed by Next-Generation Sequencing , 2014, Viruses.
[20] Gene W. Yeo,et al. Human Cytomegalovirus Infection of Human Embryonic Stem Cell-Derived Primitive Neural Stem Cells Is Restricted at Several Steps but Leads to the Persistence of Viral DNA , 2014, Journal of Virology.
[21] J. Zavadil,et al. Global reprogramming of the cellular translational landscape facilitates cytomegalovirus replication. , 2014, Cell reports.
[22] A. Brass,et al. A Novel DDB2-ATM Feedback Loop Regulates Human Cytomegalovirus Replication , 2013, Journal of Virology.
[23] Frederick S. Vizeacoumar,et al. RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs , 2013, PloS one.
[24] D. Quail,et al. Microenvironmental regulation of tumor progression and metastasis , 2014 .
[25] J. Dopazo,et al. Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin , 2013, PloS one.
[26] M. Sypabekova,et al. Role of viruses in the development of breast cancer , 2013, Infectious Agents and Cancer.
[27] J. Jensen,et al. Rapid Intrahost Evolution of Human Cytomegalovirus Is Shaped by Demography and Positive Selection , 2013, PLoS genetics.
[28] Xiaoqiang Tang. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. , 2013, Cancer letters.
[29] Amit Kumar,et al. HCMV Activates the IL-6-JAK-STAT3 Axis in HepG2 Cells and Primary Human Hepatocytes , 2013, PloS one.
[30] J. Hartman,et al. High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes , 2013, PloS one.
[31] M. L. Simpson,et al. An Endogenous Accelerator for Viral Gene Expression Confers a Fitness Advantage , 2012, Cell.
[32] Peter Kraft,et al. Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status , 2012, Journal of Medical Genetics.
[33] Karin Jirström,et al. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients , 2012, BMC Cancer.
[34] T. Kowalik,et al. Genetic Analysis of Cytomegalovirus in Malignant Gliomas , 2012, Journal of Virology.
[35] M. Szyf. DNA methylation signatures for breast cancer classification and prognosis , 2012, Genome Medicine.
[36] C. Cobbs,et al. Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype. , 2011, Cancer research.
[37] P. Siesjö,et al. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. , 2011, The Journal of clinical investigation.
[38] A. Asplund,et al. High-Risk HPV Infection and CIN Grade Correlates to the Expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a , 2011, Journal of lower genital tract disease.
[39] X. Chen,et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.
[40] G. Herbein,et al. Cytomegalovirus and Tumors: Two Players for One Goal-Immune Escape , 2011, The open virology journal.
[41] Nicholas B. Levine,et al. Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype , 2011, Clinical Cancer Research.
[42] C. Cobbs,et al. Detection of human cytomegalovirus in normal and neoplastic breast epithelium , 2010, Herpesviridae.
[43] F. Dalenc,et al. Manipulating Protein Acetylation in Breast Cancer: A Promising Approach in Combination with Hormonal Therapies? , 2010, Journal of biomedicine & biotechnology.
[44] T. Shenk,et al. Experimental human cytomegalovirus latency in CD14+ monocytes , 2010, Proceedings of the National Academy of Sciences.
[45] E. Molloy,et al. Human Cytomegalovirus UL144 Is Associated with Viremia and Infant Development Sequelae in Congenital Infection , 2010, Journal of Clinical Microbiology.
[46] Marco Siderius,et al. HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6–STAT3 Axis , 2010, Science Signaling.
[47] Johan Staaf,et al. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns , 2010, Breast Cancer Research.
[48] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[49] P. Griffiths,et al. Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens , 2010, The Journal of general virology.
[50] G. Chan,et al. Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility , 2009, Proceedings of the National Academy of Sciences.
[51] M. Jarvis,et al. A Human Cytomegalovirus gO-Null Mutant Fails To Incorporate gH/gL into the Virion Envelope and Is Unable To Enter Fibroblasts and Epithelial and Endothelial Cells , 2009, Journal of Virology.
[52] Shang-Kwei Wang,et al. Human cytomegalovirus UL76 induces chromosome aberrations , 2009, Journal of Biomedical Science.
[53] K. Khan,et al. Bcl-3-Regulated Transcription from Major Immediate-Early Promoter of Human Cytomegalovirus in Monocyte-Derived Macrophages1 , 2009, The Journal of Immunology.
[54] K. Chin,et al. Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer Progression , 2009, Clinical Cancer Research.
[55] S. Kyo,et al. Activation of telomerase by human cytomegalovirus. , 2009, Journal of the National Cancer Institute.
[56] Holger Hannemann,et al. The Presence of p53 Influences the Expression of Multiple Human Cytomegalovirus Genes at Early Times Postinfection , 2009, Journal of Virology.
[57] Brent J. Ryckman,et al. HCMV gH/gL/UL128–131 interferes with virus entry into epithelial cells: Evidence for cell type-specific receptors , 2008, Proceedings of the National Academy of Sciences.
[58] D. Coen,et al. Phosphorylation of Retinoblastoma Protein by Viral Protein with Cyclin-Dependent Kinase Function , 2008, Science.
[59] C. Söderberg-Nauclér,et al. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? , 2006, Journal of internal medicine.
[60] Brent J. Ryckman,et al. Human Cytomegalovirus Entry into Epithelial and Endothelial Cells Depends on Genes UL128 to UL150 and Occurs by Endocytosis and Low-pH Fusion , 2006, Journal of Virology.
[61] Alan Cantor,et al. Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression , 2006, Clinical Cancer Research.
[62] T. Shenk,et al. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] J. Testa,et al. Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.
[64] H. A. Rogoff,et al. Human Cytomegalovirus IE1-72 Activates Ataxia Telangiectasia Mutated Kinase and a p53/p21-Mediated Growth Arrest Response , 2005, Journal of Virology.
[65] Noriko Shirata,et al. Activation of Ataxia Telangiectasia-mutated DNA Damage Checkpoint Signal Transduction Elicited by Herpes Simplex Virus Infection* , 2005, Journal of Biological Chemistry.
[66] Goberdhan P Dimri,et al. Mammary epithelial cell transformation: insights from cell culture and mouse models , 2005, Breast Cancer Research.
[67] A. Varin,et al. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[68] L. Juan,et al. HCMV IE2‐mediated inhibition of HAT activity downregulates p53 function , 2004, The EMBO journal.
[69] J. Alexander,et al. Human Cytomegalovirus Induces Monocyte Differentiation and Migration as a Strategy for Dissemination and Persistence , 2004, Journal of Virology.
[70] M. Abba,et al. The c-myc activation in cervical carcinomas and HPV 16 infections. , 2004, Mutation research.
[71] R. Eeles,et al. ATM protein overexpression in prostate tumors: possible role in telomere maintenance. , 2004, American journal of clinical pathology.
[72] R. Myers,et al. Coding potential of laboratory and clinical strains of human cytomegalovirus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[73] C. Cobbs,et al. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. , 2003, The Journal of urology.
[74] W. Hahn,et al. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. , 2003, Cancer cell.
[75] T. Shenk,et al. Human Cytomegalovirus pp71 Stimulates Cell Cycle Progression by Inducing the Proteasome-Dependent Degradation of the Retinoblastoma Family of Tumor Suppressors , 2003, Molecular and Cellular Biology.
[76] D. Galloway,et al. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. , 2003, Carcinogenesis.
[77] C. Cobbs,et al. Human cytomegalovirus infection and expression in human malignant glioma. , 2002, Cancer research.
[78] W. Hahn,et al. Telomerase activation, cellular immortalization and cancer , 2001, Annals of medicine.
[79] M. Dell'aquila,et al. Specific chromosome 1 breaks induced by human cytomegalovirus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[80] C. López-Otín,et al. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. , 1998, Endocrine reviews.
[81] F. Hufert,et al. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection , 1998, Journal of medical virology.
[82] D. Dittmer,et al. Human cytomegalovirus infection inhibits G1/S transition , 1997, Journal of virology.
[83] J. Sinclair,et al. The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements. , 1992, The Journal of general virology.
[84] T. Albrecht,et al. Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus , 1991, Journal of virology.
[85] T. Albrecht,et al. Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection. , 1990, Science.
[86] C. Stace,et al. Where and why? , 1988, Nature.
[87] C Tuffnell,et al. Taking the strain. , 1987, The New Zealand nursing journal. Kai tiaki.
[88] F. Rapp,et al. Oncogenic transformation of human embryo lung cells by human cytomegalovirus. , 1976, Science.
[89] E. Yuliwati,et al. A Review , 2019, Current Trends and Future Developments on (Bio-) Membranes.
[90] H. Doerr,et al. The story of human cytomegalovirus and cancer: increasing evidence and open questions. , 2009, Neoplasia.
[91] H. zur Hausen,et al. The search for infectious causes of human cancers: where and why. , 2009, Virology.
[92] W. Hahn,et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.